BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of xenobiotics
,
Arthritis
,
Heart
,
Early pregnancy factor
,
Trichostatin A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
nmb cells
Summary
General Info
Curated Studies
Most Correlated Studies
Neuroblastoma cells with conditional NRAS-Q61V expression or NF1 knockout
Explore Curated Studies Results
Literature
Most Relevant Literature
Neuromedin B and Its Receptor: Gene Cloning, Tissue Distribution and Expression Levels of the Reprod…
Mice with Deletion of Neuromedin B Receptor Exhibit Decreased Oral Glucose-Stimulated Insulin Releas…
GPNMB promotes proliferation of developing eosinophils.
The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer…
Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pilot Study of Glembatumumab Vedotin Following Doxorubicin and Cytoxan as Neo-adjuvant Therapy in Gp…
Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple …
Impact of Deep Neuromuscular Blockade During Total Hip Replacement Surgery on Postoperative Recovery…
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Trial of Therapeutic Hypothermia in Patients With ARDS
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ